It was shown that the expression of XBP1, IRE1α, and GRP78 was upregulated in B-ALL patients, including BCR-ABL1 and MLLr B-ALL subsets, both at diagnosis and at relapse. Here, XBP1 is linked to acute lymphoblastic leukemia.